COLIN P DINNEY to Drug Carriers
This is a "connection" page, showing publications COLIN P DINNEY has written about Drug Carriers.
Connection Strength
0.064
-
Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude mice. J Interferon Cytokine Res. 1995 Jun; 15(6):585-92.
Score: 0.029
-
Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferon. Cancer Res. 1992 Mar 01; 52(5):1155-61.
Score: 0.023
-
In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cells. Lymphokine Cytokine Res. 1991 Dec; 10(6):487-93.
Score: 0.006
-
In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362. Cancer Immunol Immunother. 1991; 33(6):375-81.
Score: 0.005